TCDA - トリシダ (Tricida Inc.)

TCDAのニュース

   INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm  2020/08/28 20:00:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)---- $TCDA #TCDA--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc.
   Tricida to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Thursday, May 7, 2020  2020/04/30 14:00:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2020 financial results after the close of market on Thursday, May 7, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows: Tricida First Quarter 2020 Conference Call Thursday, May 7, 2020 4:30 pm Eastern Time Webcast: IR.Tricida.com Dial-in:
   Tricida to Present at the Needham Virtual Healthcare Conference  2020/04/09 15:43:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 6:20 am PT / 9:20 am ET. Tricida will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be available for 90 days following the pre
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   Wilhelm Stahl Sells 836 Shares of Tricida Inc (NASDAQ:TCDA) Stock  2019/11/15 04:13:08 Modern Readers
Tricida Inc (NASDAQ:TCDA) VP Wilhelm Stahl sold 836 shares of Tricida stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $39.97, for a total value of $33,414.92. Following the transaction, the vice president now owns 15,642 shares in the company, valued at approximately $625,210.74. The […]
   Tricida to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Thursday, May 7, 2020  2020/04/30 14:00:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2020 financial results after the close of market on Thursday, May 7, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows: Tricida First Quarter 2020 Conference Call Thursday, May 7, 2020 4:30 pm Eastern Time Webcast: IR.Tricida.com Dial-in:
   Tricida to Present at the Needham Virtual Healthcare Conference  2020/04/09 15:43:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 6:20 am PT / 9:20 am ET. Tricida will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be available for 90 days following the pre
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   Wilhelm Stahl Sells 836 Shares of Tricida Inc (NASDAQ:TCDA) Stock  2019/11/15 04:13:08 Modern Readers
Tricida Inc (NASDAQ:TCDA) VP Wilhelm Stahl sold 836 shares of Tricida stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $39.97, for a total value of $33,414.92. Following the transaction, the vice president now owns 15,642 shares in the company, valued at approximately $625,210.74. The […]
   Tricida, Inc. (TCDA) Q2 2019 Earnings Call Transcript -- The Motley Fool  2019/08/10 04:09:00 The Motley Fool
TCDA earnings call for the period ending June 30, 2019.
   Tricida to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Thursday, May 7, 2020  2020/04/30 14:00:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its first quarter 2020 financial results after the close of market on Thursday, May 7, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress. The call or webcast may be accessed as follows: Tricida First Quarter 2020 Conference Call Thursday, May 7, 2020 4:30 pm Eastern Time Webcast: IR.Tricida.com Dial-in:
   Tricida to Present at the Needham Virtual Healthcare Conference  2020/04/09 15:43:00 Business Wire
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 19th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2020 at 6:20 am PT / 9:20 am ET. Tricida will provide a company overview, business update and progress on the company’s key initiatives. A live webcast of the presentation will be accessible on the Tricida website at IR.Tricida.com. An archive of the webcast will be available for 90 days following the pre
   The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win  2019/12/12 12:38:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 11) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Aprea Therapeutics Inc (NASDAQ: APRE ) Aptose Biosciences Inc (NASDAQ: APTO ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Arvinas Inc (NASDAQ: ARVN ) Audentes Therapeutics Inc (NASDAQ: BOLD ) Axsome Therapeutics Inc (NASDAQ: AXSM ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Bausch Health Companies Inc (NYSE: BHC ) BioNTech SE – ADR (NASDAQ: BNTX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Bristol-Myers Squibb Co (NYSE: BMY ) Cue Biopharma Inc (NASDAQ: CUE ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) Forty Seven Inc (NASDAQ: FTSV ) GlaxoSmithKline plc (NYSE: GSK ) Gossamer Bio Inc (NASDAQ: GOSS ) Immunomedics, Inc. (NASDAQ: IMMU ) Incyte Corporation (NASDAQ: INCY ) IVERIC bio Inc (NASDAQ: ISEE ) Kadmon Holdings Inc (NYSE: KDMN ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Repro-Med Systems, Inc.
   Wilhelm Stahl Sells 836 Shares of Tricida Inc (NASDAQ:TCDA) Stock  2019/11/15 04:13:08 Modern Readers
Tricida Inc (NASDAQ:TCDA) VP Wilhelm Stahl sold 836 shares of Tricida stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $39.97, for a total value of $33,414.92. Following the transaction, the vice president now owns 15,642 shares in the company, valued at approximately $625,210.74. The […]
   Tricida, Inc. (TCDA) Q2 2019 Earnings Call Transcript -- The Motley Fool  2019/08/10 04:09:00 The Motley Fool
TCDA earnings call for the period ending June 30, 2019.

calendar